class=”sc-3778e872-0 cKDKQr”>
For the next course of business, the group confirms its previous growth targets.
In the first three months of 2023, the dental implant specialist made a turnover of 596 million CHF, an increase of 1.1 percent compared to the same period of the previous year. The group estimates organic growth at 3.4 percent. Traditionally, Straumann does not currently provide profit figures.
The focus is therefore on regional sales development. The Asia/Pacific region deserves special mention here, with sales of around 80 million francs, which is about 29 percent less. The main reason for this is the Chinese market, which Straumann predicts another tough year in February.
For example, patient flow in China was affected by Covid-19 in the early quarter and by the shift to volume-based supply (VBP) in the second half of the quarter.
Meanwhile, Straumann continued to grow in other regions. Revenue rose particularly strongly in Latin America, the smallest region, at +20 percent. However, the company also recorded high single-digit percentage growth in the EMEA and North America regions under its own targets.
With these numbers, Straumann slightly exceeded analysts’ expectations. Only sales in Asia were weak.
As for work progress, Straumann confirms the previous view. Accordingly, sales should grow in the high single-digit percentage range and profitability should reach 25 percent. (SDA)
Source :Blick
I’m Tim David and I work as an author for 24 Instant News, covering the Market section. With a Bachelor’s Degree in Journalism, my mission is to provide accurate, timely and insightful news coverage that helps our readers stay informed about the latest trends in the market. My writing style is focused on making complex economic topics easy to understand for everyone.
